Radar snapshot

27
Ingredients tracked
4
Fringe signals
5
Segments

Highest velocity signals this month

Hydroxyapatite — Gaining clinical legitimacy through active US trials while FDA classification for anti-caries claims stays frozen.
PAP+ whitening — Becoming the default peroxide alternative in premium whitening, led by DTC brands such as Hismile.
Charcoal toothpaste — ADA position remains unchanged despite continued consumer demand; no Seal recognition achievable.
Peri-implantitis — Being reframed as a systemic inflammatory condition, not just local, as implant volumes grow.

Current alerts

AmberCharcoal toothpaste — no ADA Seal recognition or safety consensus
AmberHydroxyapatite — unapproved for US anti-caries claims
SignalPAP+ whitening — broadening DTC adoption, no adverse safety signal
SignalHydroxyapatite trials — active US trials building the evidence base

This edition

5 new radar entries added — hydroxyapatite, oral probiotics, PAP+ whitening, charcoal, peri-implantitis
0 new red alerts — none identified this edition
2 new amber alerts, 2 new green signals
3 white space opportunities added — hydroxyapatite claims, oral probiotics, peri-implantitis